Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
02 Jun 2025
See more German company Walldorf Consulting opens new office in BarcelonaGerman company Walldorf Consulting opens new office in Barcelona
-
30 May 2025
See more U.S. company Moss Inc. is expanding its presence in Europe with a new office in BarcelonaU.S. company Moss Inc. is expanding its presence in Europe with a new office in Barcelona
-
29 May 2025
See more Catalonia strengthens economic ties with JapanCatalonia strengthens economic ties with Japan
-
26 May 2025
See more Catalonia promotes itself as a business investment hub during Catalan Week in OsakaCatalonia promotes itself as a business investment hub during Catalan Week in Osaka
